J G Kuipers1, M Koller2, F Zeman2, K Müller2, J U Rüffer3. 1. Klinik für internistische Rheumatologie, Rotes Kreuz Krankenhaus Bremen gGmbH, St. Pauli Deich 24, 28199, Bremen, Germany. kuipers.j@roteskreuzkrankenhaus.de. 2. Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany. 3. German Fatigue Society, Cologne, Germany.
Abstract
BACKGROUND: Disabilities in daily living and quality of life are key endpoints for evaluating the treatment outcome for rheumatoid arthritis (RA). Factors possibly contributing to good outcome are adherence and health literacy. METHODS: The survey included a representative nationwide sample of German rheumatologists and their patients with RA. The physician questionnaire included the disease activity score (DAS28) and medical prescriptions. The patient questionnaire included fatigue (EORTC QLQ-FA13), health assessment questionnaire (HAQ), quality of life (SF-12), health literacy (HELP), and patients' listings of their medications. Adherence was operationalized as follows: patient-reported (CQR5), behavioral (concordance between physicians' and patients' listings of medications), physician-assessed, and a combined measure of physician rating (1 = very adherent, 0 = less adherent) and the match between physicians' prescriptions and patients' accounts of their medications (1 = perfect match, 0 = no perfect match) that yielded three categories of adherence: high, medium, and low. Simple and multiple linear regressions (controlling for age, sex, smoking, drinking alcohol, and sport) were calculated using adherence and health literacy as predictor variables, and disease activity and patient-reported outcomes as dependent variables. RESULTS: 708 pairs of patient and physician questionnaires were analyzed. The mean patient age (73% women) was 60 years (SD = 12). Multiple regression analyses showed that high adherence was significantly associated with 5/7 outcome variables and health literacy with 7/7 outcome variables. CONCLUSION: Adherence and health literacy had weak but consistent effects on most outcomes. Thus, enhancing adherence and understanding of medical information could improve outcome, which should be investigated in future interventional studies.
BACKGROUND: Disabilities in daily living and quality of life are key endpoints for evaluating the treatment outcome for rheumatoid arthritis (RA). Factors possibly contributing to good outcome are adherence and health literacy. METHODS: The survey included a representative nationwide sample of German rheumatologists and their patients with RA. The physician questionnaire included the disease activity score (DAS28) and medical prescriptions. The patient questionnaire included fatigue (EORTC QLQ-FA13), health assessment questionnaire (HAQ), quality of life (SF-12), health literacy (HELP), and patients' listings of their medications. Adherence was operationalized as follows: patient-reported (CQR5), behavioral (concordance between physicians' and patients' listings of medications), physician-assessed, and a combined measure of physician rating (1 = very adherent, 0 = less adherent) and the match between physicians' prescriptions and patients' accounts of their medications (1 = perfect match, 0 = no perfect match) that yielded three categories of adherence: high, medium, and low. Simple and multiple linear regressions (controlling for age, sex, smoking, drinking alcohol, and sport) were calculated using adherence and health literacy as predictor variables, and disease activity and patient-reported outcomes as dependent variables. RESULTS: 708 pairs of patient and physician questionnaires were analyzed. The mean patient age (73% women) was 60 years (SD = 12). Multiple regression analyses showed that high adherence was significantly associated with 5/7 outcome variables and health literacy with 7/7 outcome variables. CONCLUSION: Adherence and health literacy had weak but consistent effects on most outcomes. Thus, enhancing adherence and understanding of medical information could improve outcome, which should be investigated in future interventional studies.
Authors: Patricia Katz; Maria Dall'Era; Laura Trupin; Stephanie Rush; Louise B Murphy; Cristina Lanata; Lindsey A Criswell; Jinoos Yazdany Journal: Arthritis Care Res (Hoboken) Date: 2021-01 Impact factor: 5.178
Authors: M Schwarze; V Fieguth; F Schuch; P Sandner; E Edelmann; A Händel; M Kettler; A Hanke; M Kück; L Stein; C Stille; M Fellner; V De Angelis; S Touissant; C Specker Journal: Z Rheumatol Date: 2020-09-14 Impact factor: 1.372
Authors: Karolina Müller; Jens G Kuipers; Joachim Weis; Irene Fischer; Tobias Pukrop; Jens U Rüffer; Michael Koller Journal: Rheumatol Int Date: 2021-07-16 Impact factor: 2.631